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Florian Junne1 and Stephan Zipfel1,2*Looking back on an excellent year for the Journal of
BioPsychoSocial Medicine, with numerous exciting papers
addressing topics right at core of the Journal’s interest and
often tackling issues at the forefront of international
research trends, we first and foremost like to congratulate
the Japanese Society of Psychosomatic Medicine on the
performance of its official Journal in 2014!
Given the very special honor to contribute to the New
Year’s Issue 2015 we would like to take the opportunity to
reflect on a key paradigm of the Journal of BioPsychoSocial
Medicine and the represented field of Psychosomatic
Medicine: The imperative for cross-boarder dialogue
and collaboration. One central aspect surely being the
dialogue across the boarders of the biomedical and the
psycho-social schools of thought, underpinned by the well
supported hypothesis that the complex enigma of human
existence can not be fully understood within the narrow
boundaries of one or the other scientific community.
In the following we will discuss several selected
perspectives on the dialogue and collaboration paradigm.
First, we would like to discuss examples of recently
published research related to the “stress-pandemic”.
We then turn to the health-system dimension in
underlining the importance of the trans-sectoral dialogue
in psychosomatic medicine and BioPsychoSocial research,
presenting examples of current studies on the treatment
of anorexia nervosa (one of our own main clinical and
research interests). Furthermore we would like to extend a
very warm invitation to join us on the upcoming German
Congress of Psychosomatic Medicine and Psychotherapy
in March 2015 in Berlin; where we look forward to discuss
the topic: ‘Psycho-Somatic, Dialogue Instead of Dualism’
with more then 1000 participants from all over the globe.* Correspondence: Stephan.Zipfel@med.uni-tuebingen.de
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unless otherwise stated.We conclude in paying tribute to the Japanese-German
friendship in the field of psychosomatic medicine, as a
distinct example of a fruitful dialogue across the boarders
of nations, cultures and continents.Societal dialogue: the BioPsychoSocial perspective
on the “Stress-Pandemic”
Several manuscripts published in BioPsychoSocial Medicine
in 2014 nicely illustrate the progress that was made during
past decades in terms of integration of all three dimensions
of the biopsychosocial model in clear-cut research designs.
Kato et al. for example report in their pilot-study on healthy
female nurses working in stressful environments and the
association of their depressive symptoms with serum-levels
of creatine kinase and lactate dehydrogenase [1]. They
found the investigated biomarkers to be significantly
associated with depressive symptoms in the analyzed
sample. Whilst the nature of the findings is preliminary
and indeed causation may not be inferred, the perspective
of the hypotheses and the research design of the study
may well be called “biopsychosocial”.
Such research is of importance especially in light of
the increasing prevalence of stress-related diseases in most
industrial nations. To investigate professional groups that
are exposed to extraordinary levels of stress, including
professions of the health work-force, may entail an im-
portant societal perspective as well. The latter in the sense
that the resulting evidence may inform the societal debate
and the political realm alike e.g. on the question how to
create and regulate labour markets of the future and
how to organize work place related health promotion
and preventive measures [2].
We, the community of experts for psychosomatic
medicine and biopsychosocial research, may here be asked
to inform the public in an ongoing dialogue concerning
questions such as: What levels of stress are tolerable for
whom, depending on what set of factors of resilience?
What biomarkers are suitable to predict and survey thetral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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show the highest effectiveness to prevent or treat distress
related psychosomatic diseases? What about quality of life
and societal cost-consequences of distinct levels of stress
for specific roles within certain industrial sectors? What is
the evidence base of measures practiced by people who
want to foster their individual stress-resilience or who
want to reduce stress related symptoms?
The latter question e.g. was lately addressed in
BioPsychoSocial Medicine by Yoshihara et al. who looked
at a common trend in most industrialized nations with
regards to self-administered enhancement of well-being
and stress-resistance: Yoga. In their study, the team
from the Department of Psychosomatic Medicine at
Kyushu University, found significantly reduced stress-
related symptoms after 12 weeks of regular yoga
training in their sample [4]. The attempt to analyze such
trends and to enrich the evidence base on practices
such as Yoga could be followed more consequently in
the field [5-7].
With regards to more specific stress-axis related diseases
and complex (co-) morbidities, Hara et al. analyzed the
effects of gender, age, family support and treatment on
perceived stress and the coping of patients with type-2
diabetes [8]. The study found significant gender effects on
perceived stress, coping and diet regimen in the investi-
gated sample of patients with type-2 diabetes. Age had an
effect only in males, whilst in women the “psychological
impact of diabetes” was higher than in males. The
study-team concludes that on the basis of their findings,
individualized stress and coping related interventions for
affected patients can be facilitated [8,9].
The study by Hara et al. thereby clearly refers to the
concept of “tailored interventions” which takes into
account the pattern of individual characteristics and needs
of patients when planning and conducting interventions
[8]. Besides being based on sound ethical grounds, the
tailored interventions approach promises more precise
and hence – ceteris paribus – more effective interven-
tions. To enable tailored interventions in a cost-effective
manner we do need to stay focused on the development
of specific instruments to detect relevant patterns of
patient characteristics to adjust our interventions ac-
cordingly. Saigo et al. for example, have contributed
to this area of psychometrics and psycho-diagnostic
in validating the Japanese version of the visceral sen-
sitivity index for IBS patients in a group of Japanese
University students [10]. According to the authors,
the validated new version of the instrument may now
enable e.g. the cross-cultural comparison of psychological
aspects of IBS. In practical terms however, such well
designed diagnostic instruments do substantially enrich the
most important dialogue we can engage in - the dialogue
with our individual patient [11,12].Cross-sector dialogue - the health system
perspective
With regards to the health system perspective, experts
from the field of Psychosomatic Medicine are well aware
of the unique importance of settings and conceptual
modalities in the treatment of psychosomatic diseases.
Psychosomatic entities are (in their onset and during the
course of treatment) decisively determined by the
complex interplay of individual patient characteristics,
psycho-social determinants and conceptual treatment
structures [13]. Hence, it is evident that treatment settings,
especially the health system sectors (i.e. ambulatory, day-
clinic or inpatient sector) have significantly different roles
to play or functions to fulfill along the care-continuum.
The dialogue across the treatment sectors can thereby be
seen to be of significant importance not only from a clinical
but from a health systems research perspective as well.
Indeed health service structures and practices differ
widely across countries. Nevertheless, there might be
international consensus concerning the view that the
choice of the sector where in a patient needs to be treated
primarily depends on symptom severity and on the degree
of physical impairment. However, what do we know about
the plethora of potential other characteristics that might
mediate or moderate treatment success as a function of
treatment-sector?
Kawai et al. shed some light on this important issue in
asking what psychosocial factors are associated with
immediate (urgent) inpatient admission of patients suf-
fering from anorexia nervosa [14]. The group analyzed a
total sample of 133 patients that were either urgently
admitted or scheduled for planned admission. The results
of this beautiful health services research study, primarily
confirm that BMI and the associated physical condition
are the main drivers for immediate inpatient admission at
the study-centre. None of the hypothesized psychosocial
factors showed relevant associations with the decision for
one or the other patient pathway. Kawai et al. also showed
that the urgently (because of lower BMI) admitted
group had poorer outcomes in terms of psycho-social
adjustment two years after inpatient treatment. Given
this finding one could ask whether e.g. a step-down
approach for the severely-ill patient group might be
advisable, where patients receive day-patient care following
intense inpatient treatment to facilitate the setting transfer
from inpatient to ambulatory care [14].
The latter question points to the seminal study on the
efficacy of day-patient treatment for adolescent patients
with anorexia nervosa conducted by Herpertz-Dahlmann
and colleagues [15]. The study investigated whether
day-patient treatment for adolescent non-chronic anorexia
nervosa patients is inferior to inpatient treatment with
regards to BMI at 12-months follow-up. The multi-centre
study was designed as a randomized, open-label, non-
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underwent either inpatient or day-patient treatment fol-
lowing a standardized three-week inpatient period [15].
The results show that the day-patient setting was no less
successful in the treatment of patients with anorexia ner-
vosa when measured in BMI at the 12-months follow up.
In absolute values BMI after the day-patient treatment
tended to be higher than in the inpatient group. The day-
patient setting thereby was associated with an average of
20% cost-savings (insurer perspective) at the time of dis-
charge [15]. Hence, in cost-efficacy terms the day-patient
setting was superior to the inpatient pathway in this study.
Such evidence may well justify an intensified dialogue
across health system sectors and it calls for further re-
search on the issue of optimal trans-sectoral patient
pathways including e.g. criteria dependent stepped-
care procedures with evidence based dosages.
Once a patient is transferred to the ambulatory sector
the question may arise, what exact treatment is to offer
to a patient with anorexia nervosa? The ANTOP-study
(Zipfel et al.) sought to answer such questions in
comparing Focal Psychodynamic Therapy (FPT) with
Cognitive Behavioral Therapy (CBT) against optimized
treatment as usual (TAU-O) in the treatment of adult
patients suffering from anorexia nervosa [16]. The
randomized, controlled, multi-center trial showed that
FPT was the most efficacious psychotherapeutic strategy
when looking at BMI at 12-months follow-up. CBT
however showed quicker results (increase in BMI) in
earlier treatment phases [16]. Beside the fact that the
control-arm (TAU-O) proved to be a solid basic strategy,
we might learn from the ANTOP-study that 1) specialized
(manualised) psychotherapeutic strategies have once again
proofed to be the gold-standard for the psychosomatic
and psychotherapeutic profession and 2) integrative
approaches with combinations of techniques from different
psychotherapeutic schools (e.g. FPT and CBT) are indeed a
very promising agenda of evidence based psychosomatic
medicine if we seek to optimize results for our patients.
Here again our inclination to dialogue may flourish in fos-
tering the collaboration among different psychotherapeutic
schools and traditions.
Cross-journal dialogue: joint publication initiative
on eating disorders
Given the various open questions concerning the nature
and evolution of eating disorders and the ever increasing
scientific efforts to understand the related phenomena,
we very much welcome the first joint publication initiative
of BioPsychoSocial Medicine and the Journal of Eating
Disorders on this matter. Themed “Current Status of
Eating Disorders: General and Special Population Studies”
the cross-journal thematic series called for research arti-
cles or systematic reviews that “inform on the prevalence,incidence, risk factors, morbidity and other associated
factors that have implications for primary, secondary or
tertiary prevention” of any type of eating disorder. We
ourselves look forward to the publication of this first joint
thematic series early in 2015 and kindly recommend the
issue to the similarly intrigued colleague.Congress of dialogue: the German congress of
psychosomatic medicine
Psycho – somatic, Dialogue instead of Dualism” – is
the motto 2015 of the nationally and internationally
recognized German Congress of Psychosomatic Medicine
and Psychotherapy. With the emphasis on “dialogue”
the 2015 annual conference of the German College of
Psychosomatic Medicine and Psychotherapy and the
German Society of Psychosomatic Medicine, focuses
on the dialogical nature of mind and body as well as on the
dialogue with colleagues from other medical disciplines
and e.g. renowned representatives of the humanities.
For 2015 the congress president is very pleased to host
(amongst others) renowned international key-note
speakers such as: Niall Boyce (Editor in Chief, Lancet
Psychiatry), Giovanni Fava (Editor in Chief, Psychotherapy
and Psychosomatics), Ulrike Schmidt (King’s College
London), Michael Sharpe (Oxford), Louis G. Castonguay
(Pennsylvania State University) and Peter White (London).
Furthermore, we will run research methodology oriented
courses in English language to facilitate participation of
our international guests. This track e.g. includes the high-
profile Carus-Master-Classes in research methodology.
The latter format will be held for the first time in 2015
and is subject to special application (see the English web-
site of the congress for further information). International
applications are very welcome for this format! Not only
for the Carus-Master-Classes but for the 2015 congress
at large we invite all colleagues from Japan and the
Asia-Pacific Region very warmly!Cross-continental dialogue: the Japanese-German
friendship in psychosomatic medicine
Close relationships between the Japanese and the German
Medical Community date back at least to the 19th century
when Erwin Bälz (who studied medicine at Tuebingen
University), served between 1876 and 1905 as the personal
physician to his Majesty the Emperor of Japan Meiji Tenno
Mutsuhito. More than hundred years later, we can rejoice
in the fact that especially in the field of Psychosomatic
Medicine our Societies and their members engage in an on-
going fruitful exchange about current trends and challenges
in research and practice of psychosomatic medicine! Beside
the joint initiatives by Prof. Ikemi and Prof. Schepank in
the 1980s, the close cross-continental connection was
expressed e.g. by an official agreement on collaboration
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the Society of Psychosomatic Internal Medicine in 2011.
Each year delegates from the Psychosomatic-Societies
of both countries contribute to the major conferences of
either side. For 2015 we do look forward for example to
the scientific symposium organized by our Japanese col-
leagues at the German Congress of Psychosomatic
Medicine and Psychotherapy in March 2015 in Berlin.
For this congress we also aim to conduct a Japanese-
German Case Conference as a new special format.
Conversely, delegates from e.g. the German College of
Psychosomatic Medicine took part in the Congress of
the Japanese Society of Psychosomatic Internal Medicine
in November 2014 and colleagues from Germany aim to
present their latest insights at the 56th Congress of the
Japanese Society of Psychosomatic Medicine in June 2015
in Tokyo.
As Chiharu Kubo has put it in his New Year Address
2013: To “…build strong bonds with individual re-
searchers and clinicians” [across the boarders of nations]
ultimately will also “…help us provide the best possible
care to our patients” [17].
On behalf of the German College of Psychosomatic
Medicine and the German Society of Psychosomatic
Medicine, we would like to express our deep gratitude
for the enriching personal and professional encounters
our delegates have made in past years when sharing our
views on the field of psychosomatic medicine and psy-
chotherapy with colleagues from Japan. May this excel-
lent example of a cross-continental dialogue prosper in
2015 and beyond in the best interest of both sides!
フローエス ノイエス ヤー 2015!
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